Roberta Kamin-Lewis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Roberta Kamin-Lewis has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Robert C. Gallo
Divisions of Vaccine Research and Basic Research, Institute of Human Virology, University of Maryland Biotechnology Institute, and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201
2 shared publicationsAmanda Baker
Divisions of Vaccine Research and Basic Research, Institute of Human Virology, University of Maryland Biotechnology Institute, and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201
1 shared publicationAnthony L. DeVico
Divisions of Vaccine Research and Basic Research, Institute of Human Virology, University of Maryland Biotechnology Institute, and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201
1 shared publicationBala Chandran
1 shared publicationBarbara Ensoli
1 shared publicationChristine Trang
Divisions of Vaccine Research and Basic Research, Institute of Human Virology, University of Maryland Biotechnology Institute, and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201
1 shared publication
Latest Publications
- Open Access
- 24 July 2001
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (16) , 9283-9288
Perforin-low memory CD8+cells are the predominant T cells in normal humans that synthesize the β-chemokine macrophage inflammatory protein-1β
The synthesis of antiviral β-chemokines has joined cytolysis as a potential mechanism for the control of HIV-1 infection by CD8+ T cells. Recent evidence suggests that these two effector functions can diverge in some individuals infected with HIV-1; however, little is known about the CD8+ T cell subsets in normal individuals that synthesize antiviral β-chemokines. In this report, we have used mutliparameter flow cytometry to characterize the T cell subsets that secrete the antiviral β-chemokine macrophage inflammatory protein (MIP)-1β. These studies have shown: (i) CD8+ cells are the predominant T cell subset that synthesizes MIP-1β; (ii) MIP-1β and IFN-γ are synthesized congruently in most CD8+ T cells; however, significant numbers of these cells synthesize only one of these effector molecules; (iii) approximately 60% of the CD8+ T cells that synthesize MIP-1β lack perforin; (iv) MIP-1β is synthesized with approximately equal frequency by CD28+ and CD28− subpopulations of CD8+ T cells; (v) MIP-1β is synthesized by three distinct CD8+ T cell subsets defined by the expression of CD45R0 and CD62L; and (vi) MIP-1β is not synthesized in short-term cultures of naive CD8+ T cells. These results demonstrate substantial subset heterogeneity of MIP-1β synthesis among CD8+ T cells and suggest that these subsets should be evaluated as correlates of protective immunity against HIV-1.
- 24 July 2001
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (16) , 9283-9288
Open AccessPerforin-low memory CD8+cells are the predominant T cells in normal humans that synthesize the β-chemokine macrophage inflammatory protein-1β
The synthesis of antiviral β-chemokines has joined cytolysis as a potential mechanism for the control of HIV-1 infection by CD8+ T cells. Recent evidence suggests that these two effector functions can diverge in some individuals infected with HIV-1; however, little is known about the CD8+ T cell subsets in normal individuals that synthesize antiviral β-chemokines. In this report, we have used mutliparameter flow cytometry to characterize the T cell subsets that secrete the antiviral β-chemokine macrophage inflammatory protein (MIP)-1β. These studies have shown: (i) CD8+ cells are the predominant T cell subset that synthesizes MIP-1β; (ii) MIP-1β and IFN-γ are synthesized congruently in most CD8+ T cells; however, significant numbers of these cells synthesize only one of these effector molecules; (iii) approximately 60% of the CD8+ T cells that synthesize MIP-1β lack perforin; (iv) MIP-1β is synthesized with approximately equal frequency by CD28+ and CD28− subpopulations of CD8+ T cells; (v) MIP-1β is synthesized by three distinct CD8+ T cell subsets defined by the expression of CD45R0 and CD62L; and (vi) MIP-1β is not synthesized in short-term cultures of naive CD8+ T cells. These results demonstrate substantial subset heterogeneity of MIP-1β synthesis among CD8+ T cells and suggest that these subsets should be evaluated as correlates of protective immunity against HIV-1.
- 1 April 1998
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 17 (4) , A20
INCREASED HUMAN HERPESVIRUS-8 COPY NUMBER AND VIRAL GENE EXPRESSION IN AIDS-KAPOSI'S SARCOMA PATIENTS PERIPHERAL BLOOD MONONUCLEAR CELLS CULTURED IN PRESENCE OF INFLAMMATORY CYTOKINES.
- 1 April 1998
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 17 (4) , A20
INCREASED HUMAN HERPESVIRUS-8 COPY NUMBER AND VIRAL GENE EXPRESSION IN AIDS-KAPOSI'S SARCOMA PATIENTS PERIPHERAL BLOOD MONONUCLEAR CELLS CULTURED IN PRESENCE OF INFLAMMATORY CYTOKINES.